Documenting ViaCyte’s Stem Cell Diabetes Trial – A Sweet Life
A Sweet Life |
Documenting ViaCyte’s Stem Cell Diabetes Trial
A Sweet Life Nearly 18 months into a breakthrough stem cell trial for type 1 diabetes, significant positive results are emerging. ViaCyte, a leader in stem cell therapies for diabetes, is conducting this first human trial of its kind. And a husband/wife team is … |
The Independent |
Toddlers with cataracts able to see after new stem cell treatment regrows lenses
The Independent Scientists have used a new ground-breaking new stem cell technique to enable 12 children with congenital cataracts to see. The treatment involved removing cataracts from the children’s eyes to allow the remaining stem cells to regrow functional lenses. |
